7 Services.
From First Contact to Signed Partnership.
Whatever agreement structure you're targeting : licensing, joint venture, co-development, or distribution, we cover the full cycle.
One partner. End-to-end expertise.
01. MENA Market Entry Strategy
You want to enter MENA markets, but regulatory complexity and unfamiliarity with local players is slowing your decision. We give you the clarity and roadmap to move forward with confidence.
What we deliver:
-
Comprehensive regulatory analysis: Health Canada, FDA, SFDA, MOH, EMA, multi-jurisdiction mapping
-
Competitive mapping and opportunity identification in your therapeutic segment
-
Tailored roadmap by zone: Gulf, Maghreb, Levant
-
Identification of available licensing and co-development opportunities
-
Access to our qualified distributor network time to market accelerated by up to 30%
02. Partnership Development and Execution
You have a strong product, but finding the right local partner, reliable and aligned, is the biggest barrier to your expansion. We manage the entire cycle for you.
What we deliver:
-
Pre-screened partners via 10+ years of MENA networks distributors and commercial partners
-
Trilingual expertise: language, negotiation styles, cultural expectations for each market
-
Full due diligence, deal structuring, and negotiation support through to signature
-
Legal coordination and contract finalization
03. Technology Licensing and Out-Licensing
Your intellectual property has real value in MENA unexploited without the right licensees and the right agreements. We manage the entire process.
What we deliver:
-
Strategic IP assessment and positioning across each target market
-
Identification and qualification of potential licensees in the MENA region
-
Term sheets: upfront payments, milestones, recurring royalties, royalty structure optimization
-
License agreement drafting, required registrations, and post-agreement follow-up
04. Pharmaceutical Technology Transfer
Your processes and know-how are assets few MENA players can replicate without you. Technology transfer turns this competitive advantage into sustainable revenue with your IP fully protected.
What we deliver:
-
Technical audit and feasibility assessment for transfer to MENA receiving sites
-
Full transfer plan: manufacturing processes, quality control, regulatory documentation
-
Coordination with SFDA, MOH, MOHAP, GMP compliance, alignment with Health Canada / EMA / ICH
-
Transfer agreements: IP protection, confidentiality, exploitation rights by territory
-
Post-transfer: team training, quality audits, performance KPI monitoring
05. Pharmaceutical Joint Venture MENA
Sustainable MENA presence is not built alone. A joint venture lets you share risks and accelerate growth provided it's structured correctly from the start. That's where we come in.
What we deliver:
-
Identification and qualification of the ideal local partner: strategic, financial and cultural fit
-
JV structuring: governance, capital distribution, rights and obligations of each party
-
Valuation of respective contributions drafting of founding agreements and shareholder pacts
-
Local regulatory navigation: UAE, Saudi Arabia, Morocco, Egypt and other MENA markets
-
Operational launch support and JV performance monitoring
06. Pharmaceutical Co-Development
Developing alone means carrying the full weight of costs, risks, and timelines. Co-development lets you share R&D investment with a MENA partner who brings local clinical capabilities.
What we deliver:
-
Co-development partner identification: scientific complementarity, clinical capacity, regulatory network
-
Agreement structuring: R&D investment allocation, IP rights, future revenue sharing by territory
-
Joint clinical coordination and cross-regulatory submissions (Health Canada, EMA, SFDA, MOH)
-
Agreement drafting: co-development agreement, IP ownership clauses, exit provisions
07. Pharmaceutical Co-Promotion & Co-Marketing
Your product is approved, but without field commercial presence, no sales happen. Co-promotion gives you immediate access to an established partner's salesforce. Zero delay. Maximum penetration from day one.
What we deliver:
-
Co-promotion partner: prescriber network, field coverage, hospital decision-maker access
-
Agreement structuring: territories, revenue split, promotional responsibilities, exclusivity
-
Product positioning and marketing message alignment for each target market
-
Commercial KPIs, reporting, audit mechanisms
-
Full legal: co-promotion agreement, performance clauses, termination conditions